العودة إلى لوحة التحكم / Back to Dashboard

Electrolyte Abnormalities in Patients Receiving Diuretics for Heart Failure.

ETH-20260205-0117 تاريخ التقديم: Feb 05, 2026 / Submitted: Feb 05, 2026
قيمة الرسوم / Payment Amount
21,000.00 SDG
نوع البحث / Research Type
ورقة علمية / Research Paper
فترة الدراسة / Study Period
Feb 12, 2026 - Jun 12, 2026
Approved
السودان - الولاية الشمالية
وزارة الصحة
الادارة العامة للتخطيط والتنمية الصحية
إدارة البحوث
لجنة الموافقة الأخلاقية
طلب الموافقة الأخلاقية - Ethical Approval Request Form
---
Ethical Approval Request Form
General Administration for Planning and Health Development
Research Department
Ethical Approval Committee
---
رقم التسلسل
Serial Number
SER-20260205-0117
رقم الطلب
Request Number
ETH-20260205-0117
تاريخ تقديم الطلب
Date of Submission
2026-02-05

القسم الأول: معلومات الباحث / Principal Investigator Information

1. الاسم الكامل للباحث الرئيسي
Principal Investigator Full Name
Thoraya Salah Murtada Sidahmed
2. الجهة التي ينتمي إليها
Affiliation Type
جامعة / University: Alzaiem Alazhary University - Faculty of Medicine
Alzaiem Alazhary University - Faculty of Medicine
3. الوظيفة / اللقب العلمي
Job Title/Academic Degree
-
4. البريد الإلكتروني
Email Address
thorayagzzar@gmail.com
5. رقم الهاتف
Phone Number
00249119308727
المشرف / Supervisor
الاسم الكامل / Full Name
Dalal Nooreldein Mohamadin
البريد الإلكتروني / Email
dalal.nooreldein@gmail.com
الوظيفة / اللقب العلمي / Job Title
Internal Medicine Specialist
رقم الهاتف / Phone
-
القسم / المؤسسة / Department
-

القسم الثاني: تفاصيل الدراسة البحثية / Research Study Details

7. عنوان الدراسة
Study Title
Electrolyte Abnormalities in Patients Receiving Diuretics for Heart Failure.
8. نوع البحث (يرجى التحديد)
Type of Research (Please select)
☐دكتوراه / PhD
☐ماجستير / Master's
☐بكالوريوس / Bachelor's
☐دبلوم عالي / Postgraduate Diploma
☐دبلوم وسيط / Intermediate Diploma
☑ورقة علمية / Research Paper
☐تقرير علمي / Scientific Report
☐أبحاث طبية / Medical Research
☐أخرى / Other
9. وصف مختصر للبحث
Brief Description of Research
Problem Statement Diuretics are widely used in managing heart failure but are associated with electrolyte disturbances, including hyponatremia and hypokalemia, which can worsen cardiac outcomes. In Sudanese hospitals, electrolyte monitoring is often limited, and local data on the prevalence and patterns of such abnormalities are lacking. Justification Identifying the prevalence and determinants of electrolyte abnormalities among diuretic-treated HF patients will guide safer prescribing practices, improve monitoring, and prevent adverse events. General Objective To determine the prevalence and types of electrolyte abnormalities in patients receiving diuretics for heart failure at Dongola Specialized Hospital. Specific Objectives 1. To determine the prevalence of hyponatremia, hypokalemia, and hypomagnesemia. 2. To identify risk factors associated with electrolyte abnormalities. 3. To assess the relationship between diuretic type, dose, and electrolyte disturbance. Methodology • Study Design: Hospital-based cross-sectional study. • Study Area: Dongola Specialized Hospital. • Study Population: Heart failure patients on diuretic therapy admitted to or attending the medical ward or outpatient clinic. • Sample Size: Calculated using a prevalence-based formula; expected around 100–150 patients. • Data Collection: Structured data collection form including demographic data, clinical information, medication type, and recent serum electrolytes. • Data Analysis: SPSS will be used; descriptive statistics and logistic regression will determine predictors. • Ethical Considerations: Ethical approval and patient consent will be obtained. Anticipated Outcomes Epidemiological Data: The study will provide the first localized data on the prevalence of hyponatremia, hypokalemia, and hypomagnesemia specifically within the Dongola region, identifying the scale of the clinical problem. Risk Profile Identification: By the end of the study, we expect to identify specific patient subsets (e.g., elderly patients or those on specific dosages) who are at the highest risk for life-threatening imbalances. Clinical Guidelines: Findings will serve as a basis for developing a standardized electrolyte monitoring protocol at Dongola Specialized Hospital to ensure safer diuretic administration. Reduced Morbidity: By highlighting the correlation between diuretic types and disturbances, the research will encourage preventative supplementation or dosage adjustments, potentially reducing re-hospitalization rates and cardiac arrhythmias. Foundation for Future Research: This data will act as a baseline for prospective studies evaluating the long-term impact of electrolyte management on heart failure mortality in Northern Sudan.

القسم الثالث: الجوانب الأخلاقية / Ethical Considerations

10. طريقة الحصول على الموافقة من المشاركين
Method of Obtaining Consent from Participants
☑مكتوبة / Written
☐شفهية / Verbal
☐غير مطبقة / Not Applicable
☐ضمنية / Implied
☐إعفاء / Waiver
يرجى إرفاق نموذج الموافقة / Please attach consent form
11. آلية الحفاظ على سرية المعلومات
Confidentiality Measures
We will obtain written informed consent from every patient before any data is collected. All records will be anonymized by removing names and using unique ID numbers instead, ensuring that no individual can be identified in the final report. Access to the data will be strictly limited to the research team, and all personal information will remain completely confidential.
12. مدى المخاطر على المشاركين
Risk Level to Participants
☐لا توجد / None
☑طفيفة / Minor
☐متوسطة / Moderate
☐عالية / High
يرجى توضيح أي مخاطر محتملة وخطة التعامل معها / Please describe any potential risks and mitigation:
This study poses no significant risk to participants. It is an observational study that relies on routine clinical data.
13. الفوائد المحتملة للمشاركين أو المجتمع
Potential Benefits to Participants or Society
The data will fill a significant gap in local medical knowledge, providing a foundation for improving heart failure treatment strategies throughout Sudan
14. هل تشمل الدراسة فئات ضعيفة؟
Does the study involve vulnerable groups?
☐الأطفال / Children
☐النساء الحوامل / Pregnant Women
☐اللاجئون/النازحون / Refugees/Displaced
☐ذوو الإعاقة / People with Disabilities
☐أخرى / Other:

القسم الرابع: قائمة المرفقات المطلوبة / Required Attachments

نسخة من المقترح البحثي الكامل
Full Research Proposal
أدوات جمع البيانات
Data Collection Tools
خطاب تسهيل من الجامعة
University Facilitation Letter

القسم الخامس: الإقرار والتوقيع / Acknowledgment and Signature

أُقر أنا الموقع أدناه بأن جميع المعلومات الواردة في هذه الاستمارة صحيحة وكاملة، وأتعهد بعدم البدء في أي جزء من الدراسة قبل الحصول على الموافقة الأخلاقية الرسمية، والالتزام بجميع الإرشادات والمعايير الأخلاقية المعتمدة من قبل لجنة الموافقة الأخلاقية.
I, the undersigned, acknowledge that all information provided in this form is accurate and complete, and I agree not to begin any part of the study before receiving official ethical approval, and to comply with all ethical guidelines and standards approved by the Ethical Approval Committee.
اسم الباحث الرئيسي / Principal Investigator Name
Thoraya Salah Murtada Sidahmed
التوقيع / Signature
_______________________
التاريخ / Date
2026-02-05

معلومات الباحث / Researcher Information

T

Thoraya Salah Murtada Sidahmed

thorayagzzar@gmail.com

00249119308727

جامعة: Alzaiem Alazhary University الكلية: Faculty of Medicine

Dongola Specialized Hospital

اسم المؤسسة التي سيتم فيها عمل البحث / Name of the institution where the research will be conducted

Sudan - Northern state - Dongola

معلومات الدراسة / Study Information

ورقة علمية / Research Paper

messages.degree_research_paper - messages.degree_research_paper

21,000.00 SDG

Problem Statement Diuretics are widely used in managing heart failure but are associated with electrolyte disturbances, including hyponatremia and hypokalemia, which can worsen cardiac outcomes. In Sudanese hospitals, electrolyte monitoring is often limited, and local data on the prevalence and patterns of such abnormalities are lacking. Justification Identifying the prevalence and determinants of electrolyte abnormalities among diuretic-treated HF patients will guide safer prescribing practices, improve monitoring, and prevent adverse events. General Objective To determine the prevalence and types of electrolyte abnormalities in patients receiving diuretics for heart failure at Dongola Specialized Hospital. Specific Objectives 1. To determine the prevalence of hyponatremia, hypokalemia, and hypomagnesemia. 2. To identify risk factors associated with electrolyte abnormalities. 3. To assess the relationship between diuretic type, dose, and electrolyte disturbance. Methodology • Study Design: Hospital-based cross-sectional study. • Study Area: Dongola Specialized Hospital. • Study Population: Heart failure patients on diuretic therapy admitted to or attending the medical ward or outpatient clinic. • Sample Size: Calculated using a prevalence-based formula; expected around 100–150 patients. • Data Collection: Structured data collection form including demographic data, clinical information, medication type, and recent serum electrolytes. • Data Analysis: SPSS will be used; descriptive statistics and logistic regression will determine predictors. • Ethical Considerations: Ethical approval and patient consent will be obtained. Anticipated Outcomes Epidemiological Data: The study will provide the first localized data on the prevalence of hyponatremia, hypokalemia, and hypomagnesemia specifically within the Dongola region, identifying the scale of the clinical problem. Risk Profile Identification: By the end of the study, we expect to identify specific patient subsets (e.g., elderly patients or those on specific dosages) who are at the highest risk for life-threatening imbalances. Clinical Guidelines: Findings will serve as a basis for developing a standardized electrolyte monitoring protocol at Dongola Specialized Hospital to ensure safer diuretic administration. Reduced Morbidity: By highlighting the correlation between diuretic types and disturbances, the research will encourage preventative supplementation or dosage adjustments, potentially reducing re-hospitalization rates and cardiac arrhythmias. Foundation for Future Research: This data will act as a baseline for prospective studies evaluating the long-term impact of electrolyte management on heart failure mortality in Northern Sudan.

Feb 12, 2026 - Jun 12, 2026

Feb 15, 2026 - Apr 15, 2026

الاعتبارات الأخلاقية / Ethical Considerations

Written

مخاطر منخفضة - Low Risk

We will obtain written informed consent from every patient before any data is collected. All records will be anonymized by removing names and using unique ID numbers instead, ensuring that no individual can be identified in the final report. Access to the data will be strictly limited to the research team, and all personal information will remain completely confidential.

This study poses no significant risk to participants. It is an observational study that relies on routine clinical data.

The data will fill a significant gap in local medical knowledge, providing a foundation for improving heart failure treatment strategies throughout Sudan

Elderly